Abbott receives fda clearance for whole blood rapid test to help with assessment of concussion at the patient's bedside

The test, run on abbott's portable i-stat® alinity® instrument, uses whole blood to help evaluate patients with a suspected mild traumatic brain injury (mtbi), or concussion the test produces lab-quality results in 15 minutes clinicians are now able to get a result at the patient's bedside, making the test accessible at urgent care clinics and other healthcare settings outside the hospital emergency room the test can be used to help evaluate patients up to 24 hours after injury abbott park, ill., april 1, 2024 /prnewswire/ -- abbott's i-stat tbi cartridge has received clearance from the u.s. food and drug administration (fda) to be used with whole blood, allowing doctors to help assess patients with suspected concussion at the patient's bedside and obtain lab-quality results in 15 minutes.
ABT Ratings Summary
ABT Quant Ranking